+629.1%
MRNA vs FITB
+181.1%
+448.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.6% | -2.8% | -3.3% |
| 7D | -10.1% | -0.4% | -9.7% | -10.0% |
| 30D | +126.7% | -5.1% | +131.9% | +127.3% |
| 3M | +184.1% | +3.5% | +180.6% | +180.8% |
| 6M | +143.3% | +17.2% | +126.1% | +135.7% |
| YTD | +359.9% | +17.6% | +342.2% | +345.0% |
| 1Y | +454.2% | +23.4% | +430.8% | +432.3% |
| 3Y | +26.0% | +129.7% | -103.8% | +14.2% |
| 5Y | -70.3% | +68.4% | -138.7% | -72.6% |
| All | +629.1% | +181.1% | +448.0% | +683.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling